EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 02002R1490-20100907

Consolidated text: Commission Regulation (EC) No 1490/2002 of 14 August 2002 laying down further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC and amending Regulation (EC) No 451/2000 (Text with EEA relevance)

ELI: http://data.europa.eu/eli/reg/2002/1490/2010-09-07

02002R1490 — EN — 07.09.2010 — 004.001


This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B

COMMISSION REGULATION (EC) No 1490/2002

of 14 August 2002

laying down further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC and amending Regulation (EC) No 451/2000

(Text with EEA relevance)

(OJ L 224 21.8.2002, p. 23)

Amended by:

 

 

Official Journal

  No

page

date

►M1

COMMISSION REGULATION (EC) No 1044/2003 of 18 June 2003

  L 151

32

19.6.2003

►M2

COMMISSION REGULATION (EC) No 1744/2004 of 7 October 2004

  L 311

23

8.10.2004

►M3

COMMISSION REGULATION (EC) No 1095/2007 of 20 September 2007

  L 246

19

21.9.2007

►M4

COMMISSION REGULATION (EU) No 741/2010 of 17 August 2010

  L 217

2

18.8.2010




▼B

COMMISSION REGULATION (EC) No 1490/2002

of 14 August 2002

laying down further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC and amending Regulation (EC) No 451/2000

(Text with EEA relevance)



Article 1

Subject matter and scope

1.  
This Regulation lays down further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Directive 91/414/EEC with respect to the continued evaluation of the active substances notified under Regulation (EC) No 451/2000.
2.  
Article 6(2), (3) and (4), second subparagraph, of Directive 91/414/EEC shall not apply to a substance listed in Annex I to this Regulation as long as the procedures provided for in this Regulation with regard to these substances have not been finalised.
3.  

This Regulation shall apply without prejudice to:

(a) 

reviews by Member States of active substances in Annex I in particular pursuant to renewals of authorisations in accordance with Article 4(4) of Directive 91/414/EEC;

(b) 

reviews by the Commission pursuant to Article 5(5) of Directive 91/414/EEC;

(c) 

assessments carried out under Directive 79/117/EEC.

Article 2

Definitions

For the purpose of this Regulation, the definitions in Directive 91/414/EEC shall apply.

The following definitions shall also apply:

(a) 

‘notifier’ means the natural or legal person who submitted a notification in accordance with the terms specified in Regulation (EC) No 451/2000 as listed in Annex II;

(b) 

‘Committee’ means the Standing Committee on the Food Chain and Animal Health, referred to in Article 19 of Directive 91/414/EEC;

(c) 

‘data list’ means a list of all the data which is available to be submitted in the full data package;

(d) 

‘full data package’ means information and results of studies sufficient to satisfy the requirements of Annexes II and III to Directive 91/414/EEC in relation to a limited range of representative uses of the active substance concerned.

Article 3

Member State authority

1.  
Member States shall allocate responsibility for the implementation of their obligations under the programme of work referred to in Article 8(2) of Directive 91/414/EEC to an authority or authorities.
2.  
Each Member State shall designate one national authority, referred to in Annex III, to coordinate and ensure all necessary contacts with notifiers, other Member States, the Commission and the European Food Safety Authority (EFSA) pursuant to this Regulation. Each Member State shall inform the details concerning the designated coordinating national authority to the Commission, the EFSA and the designated coordinating national authority of each other Member State and of any modifications thereof.

Article 4

Measures in case of imbalances

If, during the assessment and evaluation referred to in Articles 9 and 10, it becomes apparent that there is an imbalance in the responsibilities borne and the work to be done or actually done by the Member States as rapporteurs, it may be decided, in accordance with the procedure provided for in Article 19 of Directive 91/414/EEC, to replace a Member State originally designated as rapporteur for a particular active substance by another Member State.

In such cases the original rapporteur Member State shall inform the notifiers concerned and shall transfer to the newly designated rapporteur Member State all correspondence and information which it has received as rapporteur Member State for the active substance concerned. The original Member State shall return to the notifier the fee referred to in Article 17 except for the part referred to in paragraph 2(d) thereof. The newly designated rapporteur Member State shall then require the notifiers to pay the fee referred to in Article 17 except the part referred to in paragraph 2(d) thereof.

Article 5

Withdrawal or replacement of notifier

1.  
If a notifier decides to end its participation in the programme of work for an active substance, it shall immediately inform the rapporteur Member State, the Commission, the EFSA and all other notifiers of the substance concerned of its decision, giving the reasons. Where a notifier ends its participation or fails to fulfil its obligations under this Regulation, the procedures provided for in Article 9 or 10 shall be terminated as regards its dossier.
2.  
If a notifier agrees with another producer that the notifier shall be replaced for the purposes of further participation in the programme of work under this Regulation, the notifier and such other producer shall inform the rapporteur Member State, the Commission and the EFSA by a common declaration agreeing that such other producer shall replace the original notifier in carrying out the notifier's duties pursuant to Articles 6, 7, 9, 10 or 11. They shall ensure that the other notifiers for the substance concerned are informed at the same time. The other producer in this case shall be jointly liable with the original notifier for any fees remaining payable in relation to the notifier's application under the regime established by Member States pursuant to Article 17.
3.  
All information submitted shall remain available to the rapporteur Member States, the Commission or the EFSA.

Article 6

Submission and checking of data lists

1.  
By 23 May 2003 at the latest, the notifier(s) shall submit to the relevant rapporteur Member State the data lists for active substances listed in Annex I, and submit a copy to the EFSA.

Where, for any active substance listed in Annex I, there are several notifications, the notifiers concerned shall take all reasonable steps to submit these data lists collectively.

Where a data list is not submitted by all notifiers concerned, it shall mention the efforts made and the reasons why certain notifiers have not participated.

For active substances notified by more than one notifier those notifiers shall for each study involving vertebrate animals, detail the attempts made to avoid duplication of testing and give, if applicable, the reasons for conducting a duplicate study.

2.  
The data lists shall be prepared in the format specified in accordance with the procedure provided for in Article 19 of Directive 91/414/EEC. The full data package, as defined in Article 10(4) of Regulation (EC) No 451/2000, shall be kept available by the notifiers. On written request from the rapporteur Member State or the Commission, the notifier shall provide without delay, the part of the data package or the full data package requested.
3.  
The rapporteur Member State shall examine the data lists submitted to establish whether they indicate that a full data package is available to be submitted. For those active substances for which a rapporteur Member State considers that no full data package is available to be submitted, the rapporteur Member State shall request the notifier to submit without delay a full data package and check whether it is complete. The rapporteur Member State shall report the results of these checks to the Commission at the latest within three months of receipt of the data lists.
4.  
For those active substances for which the rapporteur Member State considers that no full data package is available it shall inform the Commission without delay. In accordance with the procedure provided for in Article 19 of Directive 91/414/EEC, it shall be decided whether a full data package is available.
5.  
Where it is considered that no full data package is available for a particular active substance, the Commission shall decide, as provided for in the fourth subparagraph of Article 8(2) of Directive 91/414/EEC, not to include the active substance concerned in Annex I to Directive 91/414/EEC.
6.  
Unless the Commission informs the notifier that no full data package is available for a particular active substance, the notifier shall submit the dossiers referred to in Article 7(2) and (3) by the time limits specified in Article 7(1).

Article 7

Submission of dossiers

1.  
The notifier(s) shall submit to the relevant rapporteur Member State the summary dossier referred to in paragraph 2 and the complete dossier referred to in paragraph 3, by 30 November 2003 at the latest for active substances listed in Annex I, part A, and by 30 November 2004 at the latest for active substances listed in Annex I, part B.

Where for any active substance listed in Annex I there are several notifications, the notifiers concerned shall take all reasonable steps to submit these dossiers collectively.

Where a dossier is not submitted by all notifiers concerned, it shall mention the efforts made and the reasons why certain notifiers have not participated.

For active substances notified by more than one notifier, those notifiers shall for each study involving vertebrate animals, detail the attempts made to avoid duplication of testing and give, if applicable, the reasons for conducting a duplicate study.

2.  

The summary dossier shall include the following:

(a) 

a copy of the notification; in the case of a joint application made by several producers, a copy of the notifications made in accordance with Article 10 of Regulation (EC) No 451/2000 and the name of the person designated by the producers concerned as being responsible for the joint dossier and the processing of the dossier in accordance with this Regulation;

(b) 

a limited range of representative uses of the active substance, in respect of which the data submitted by the notifier in the dossier shall demonstrate that for one or more preparations, the requirements set out in Article 5 of Directive 91/414/EEC for inclusion of the active substance in Annex I to Directive 91/414/EEC, can be met;

(c) 
(i) 

for each point of Annex II to Directive 91/414/EEC, the summaries and results of studies and trials, the name of the person or institute that has carried out the trials;

(ii) 

for each point of Annex III to Directive 91/414/EEC the summaries and results of studies and trials, the name of the person or institute that has carried out the trials, relevant to the assessment of the criteria referred to in Article 5 of Directive 91/414/EEC for one or more preparations which are representative for the uses referred to in subparagraph (b) taking into account that data gaps in the information of the Annex II dossier resulting from the proposed limited range of representative uses of the active substance may lead to restrictions in the inclusion into Annex I to Directive 91/414/EEC;

(iii) 

and for active substances listed in Annex I, part B, for studies not yet fully completed the evidence that these studies have been commissioned as required by Article 10(4) of Regulation (EC) No 451/2000 with an undertaking that they will be submitted at the latest by 31 May 2005;

(d) 

a checklist to be filled in by the notifier, demonstrating that the dossier is complete.

3.  
The complete dossier shall physically contain the individual test and study reports concerning all the information referred to in paragraph 2(c), or the evidence referred to in paragraph 2(c)(iii) where work is in progress.
4.  
Each Member State shall define the number of copies and the format of the summary and the complete dossiers to be submitted by the notifiers. In defining the format of the dossier Member States shall take account of the recommendations made in accordance with the procedure provided for in Article 19 of Directive 91/414/EEC.
5.  
Where the dossiers or any part of them are not sent within the relevant time limit, the rapporteur Member State shall inform the Commission and the EFSA within two months, giving any justification for the delay provided by the notifiers.
6.  
On the basis of the information transmitted by the rapporteur Member State in accordance with paragraph 5, the Commission shall determine whether the notifier has demonstrated that the delay in submission of the dossier was caused by force majeure. In this case, it shall establish a new time limit for the submission of a dossier fulfilling the requirements of paragraphs 2 and 3 in accordance with the procedure provided for in Article 19 of Directive 91/414/EEC.
7.  
The Commission shall decide, as provided for in the fourth subparagraph of Article 8(2) of Directive 91/414/EEC, not to include in Annex I to Directive 91/414/EEC an active substance for which no dossier has been submitted within the established time limit.

Article 8

Submission of information by third parties

Any person wishing to submit information which might contribute to the evaluation, in particular with regard to the potentially dangerous effects of the active substance or its residues on human and animal health and on the environment to the rapporteur Member States shall do so by 30 November 2003 at the latest for substances listed in Annex I, part A, and by 30 November 2004 at the latest for substances listed in Annex I, part B. The rapporteur Member State shall submit any information received to the EFSA.

Article 9

Completeness check of dossiers

1.  
For each active substance for which it has been designated rapporteur, the Member State shall examine the dossiers referred to in Article 7(2) and (3) and assess the checklists provided by the notifiers. The rapporteur Member State shall at the latest six months after the receipt of all dossiers for an active substance report to the EFSA and the Commission on the completeness of the dossiers.

The EFSA shall assess the reports submitted to it by the rapporteur Member States and report to the Commission on the completeness of the dossiers.

For those active substances for which one or more dossiers are considered to be complete, the rapporteur Member State shall perform the evaluation as referred to in Article 10, unless the EFSA informs the rapporteur Member State and the Commission, within two months of receipt of the Member State report on completeness, that it does not consider the dossier to be complete.

For those active substances for which the dossier is to be completed, as provided for under Article 7(2)(c)(iii), the report must confirm the date by which the dossier will be completed and by which date the evaluation as referred to in Article 10 will begin.

2.  
For those active substances for which a rapporteur Member State or the EFSA consider that the dossier is not complete within the meaning of Article 7(2) and (3), the Commission shall, within three months after the receipt of the report of the rapporteur Member State or the EFSA, refer such report to the Committee. In accordance with the procedure provided for in Article 19 of Directive 91/414/EEC, it shall be decided whether a dossier is considered complete within the meaning of Article 7(2) and (3).
3.  
The Commission shall decide, as provided for in the fourth subparagraph of Article 8(2) of Directive 91/414/EEC, not to include in Annex I to Directive 91/414/EEC an active substance for which no complete dossier has been submitted within the prescribed time limit.

Article 10

Evaluation by the rapporteur Member State

1.  
The rapporteur Member State shall evaluate and report only on those active substances for which at least one dossier has been determined to be complete in accordance with Article 9. For such active substances it shall evaluate and report only on the complete dossiers and for the other dossiers it shall check the identity and impurities of the active substance. The rapporteur Member State shall take into consideration the information available on potentially dangerous effects in the other dossiers submitted by any notifier or by any third party in accordance with the provisions of Article 8. It shall send a draft report of its assessment of the dossier to the EFSA as quickly as possible, and at the latest 12 months after the dossier was determined to be complete. The draft assessment report shall be submitted in the format recommended in accordance with the procedure provided for in Article 19 of Directive 91/414/EEC.

At the same time, the rapporteur Member State shall make a recommendation to the Commission either:

— 
to include the active substance in Annex I to Directive 91/414/EEC, stating the conditions for inclusion, or
— 
not to include the active substance in Annex I to Directive 91/414/EEC, stating the reasons for the non-inclusion.

The rapporteur Member State shall in particular include in the draft assessment report a reference to each test and study report, for each point of Annex II and Annex III to Directive 91/414/EEC, relied on for the assessment. This reference shall be made in the form of a list of test and study reports including the title, the author(s), the date of the study or test report and the date of publication, the standard to which the test or study was conducted, the holder's name and, if any, the claim made by the holder or notifier for data protection. It shall also mention for the other notified sources of the active substances for which the dossier was considered not to be complete whether it can be concluded that such active substances are comparable within the meaning of Article 13(5) of Directive 91/414/EEC.

2.  
Without prejudice to Article 7 of Directive 91/414/EEC, submission of new studies shall not be accepted except for the studies as specified in Article 10(4) of Regulation (EC) No 451/2000. The rapporteur Member State may however request the notifiers to submit further data which are necessary to clarify the dossier. When doing so the rapporteur Member State shall set a time limit within which the information should be provided; this time limit shall not affect the time limit for the submission of the report referred to in paragraph 1.

The rapporteur Member State may, from the start of its examination of the dossier, consult with experts from the EFSA and may request additional technical or scientific information from other Member States to assist the evaluation. The rapporteur Member State may perform the evaluation together with a co-rapporteur Member State.

The rapporteur Member State shall request the notifiers to submit an updated summary dossier to the EFSA, the other Member States and on request to the Commission at the same time as the rapporteur's draft assessment report is sent to the EFSA.

The Member States, the Commission or the EFSA may request through the rapporteur Member State that notifiers also send them an updated complete dossier or parts thereof.

3.  
As soon as it becomes evident to a rapporteur Member State that it will be unable to comply with the time limit specified in paragraph 1 for the submission of the draft assessment report to the EFSA, it shall inform the Commission and the EFSA and give the reasons for the delay. Where necessary, certain active substances may be reassigned to another Member State in accordance with the procedure provided for in Article 19 of Directive 91/414/EEC.

▼M3

Article 11

Receipt of and access to the draft assessment report

1.  
After receiving the updated summary dossier and the draft assessment report referred to in Article 10(1) the EFSA shall, within 30 days, acknowledge to the rapporteur Member State receipt of that report.

In exceptional cases where the draft assessment report clearly does not fulfil the requirements concerning the format recommended by the Commission, the Commission shall agree with the EFSA and the rapporteur Member State on a period for resubmission of an amended report. This period shall not exceed two months.

2.  
The EFSA shall without delay communicate the draft assessment report to the Commission, the other Member States and the notifiers setting a time period of no more than two months for the submission of comments by those Member States and the notifiers.

It shall collate the comments it receives, including available comments from the EFSA, and forward them to the Commission, Member States and the notifiers.

3.  

The EFSA shall make available at specific request or keep available for consultation by any person the following:

(a) 

the draft assessment report except the elements thereof which have been accepted as confidential in accordance with Article 14 of Directive 91/414/EEC;

(b) 

the list of any data required for the evaluation in view of the possible inclusion of the active substance in Annex I to that Directive as finalised by the EFSA where it has finalised such a list.

Article 11a

Examination of the draft assessment report

The Commission shall, without delay, examine the draft assessment report and the recommendation by the rapporteur Member State and the comments received from other Member States, the EFSA and from the notifiers in accordance with Article 11(2).

Article 11b

Active substance with clear indications that they do not have any harmful effects

If there are clear indications that it may be expected that the active substance does not have any harmful effects on human or animal health or on groundwater or any unacceptable influence on the environment, as set out in Annex V, Article 12(1)(a) and (2)(a) shall apply.

Article 11c

Consultation of the EFSA

1.  
Where Article 11b does not apply, the Commission may, at any time during the evaluation, ask the EFSA to carry out a peer review of the full draft assessment report or to focus on specific points including points related to criteria set out in Annex VI. The EFSA shall organise a consultation of Member States experts including the rapporteur Member State.

Where the Commission requests the EFSA to carry out a full peer review, the EFSA shall deliver its conclusion at the latest six months after the request. Where the Commission does not request a full peer review, but only a conclusion on specific points, the period shall be reduced to three months. The submission of the conclusions shall in any event be no later than 30 September 2008.

2.  
If during the peer review there are clear indications that an active substance is expected to have harmful effects on human or animal health or on groundwater as set out in Annex VI, the EFSA shall inform the Commission.

The Commission may take a Decision as referred to in Article 11f.

3.  
The Commission and the EFSA shall agree on a schedule for the delivery of the conclusions in order to facilitate the planning of the work. The Commission and the EFSA shall agree on the format in which the conclusions of the EFSA are submitted.

Article 11d

Submission of additional information after the draft assessment report has been submitted to the EFSA

1.  
Without prejudice to Article 7 of Directive 91/414/EEC, submission of new studies shall not be accepted.
2.  
Where the EFSA considers that additional information from the notifier is necessary to comply with a request made by the Commission under Article 11c, the rapporteur Member State shall request that information. Such requests shall be made explicitly and in writing, setting a time period for submission of one month. They shall not concern the submission of new studies. The rapporteur Member State shall inform the Commission and the EFSA of such requests in writing.

The rapporteur Member State shall, within one month after the receipt of such information, evaluate the information received and send its evaluation to the EFSA.

3.  
Information submitted by the notifier but which has not been requested, or which has not been submitted before the end of the time period referred to in paragraph 2, shall not be taken into account unless this information has been submitted in accordance with Article 7 of Directive 91/414/EEC.

Where the rapporteur Member State, pursuant to paragraph 1 or to the first subparagraph of this paragraph, refuses to take into account studies or information received from the notifier, it shall inform the Commission and the EFSA and indicate the reasons for such refusal.

Article 11e

Withdrawal by notifier

Where Article 11b does not apply, the notifier may withdraw his support of the inclusion of the active substance in Annex I to Directive 91/414/EEC within two months from receipt of the draft assessment report referred to in Article 11(2).

Article 11f

Active substance for which there are clear indications of harmful effects

If there are clear indications that it may be expected that the active substance has harmful effects on human or animal health or on groundwater as set out in Annex VI, the Commission shall take a Decision on the non-inclusion of the active substance in Annex I to Directive 91/414/EEC, in accordance with Article 12(1)(a) and (2)(b) of this Regulation.

Article 12

Presentation of a draft directive or draft decision

1.  

The Commission shall submit to the Committee a draft review report at the latest six months after:

(a) 

receipt of the draft assessment report where Article 11b or Article 11f applies;

(b) 

receipt of the conclusion established by the EFSA where Article 11c applies;

(c) 

receipt of a written withdrawal of the notifier’s support where Article 11e applies.

2.  

Together with the draft review report the Commission shall submit to the Committee:

(a) 

a draft directive including the active substance in Annex I to Directive 91/414/EEC, setting out where appropriate the conditions, including the time limit, for such inclusion; or

(b) 

a draft decision addressed to the Member States requiring them to withdraw, within six months, the authorisations of plant protection products containing the active substance, pursuant to the fourth subparagraph of Article 8(2) of Directive 91/414/EEC, whereby that active substance is not included in Annex I to that Directive, mentioning the reasons for the non-inclusion.

The Directive or Decision shall be adopted in accordance with the procedure referred to in Article 19(2) of Directive 91/414/EEC.

3.  
By way of derogation from paragraph 2(b), the latest date for Member States to withdraw authorisations shall be 31 December 2010 in the case referred to in paragraph 1(c) unless the Commission has concluded that the substance meets the criteria of Annex VI, if appropriate after having consulted the EFSA. ►M4   However, the latest date for Member States to withdraw authorisations shall be 31 December 2011 where an application has been submitted in accordance with the accelerated procedure provided for in Articles 14 to 19 of Commission Regulation (EC) No 33/2008 ( 9 ). ◄

Article 12a

View by the EFSA

Where an active substance is included in Annex I to Directive 91/414/EEC pursuant to Article 11b of this Regulation, the Commission shall request the EFSA to deliver its view on the draft review report by 31 December 2010 at the latest. Member States and notifiers shall cooperate with the EFSA and the Commission.

In order to facilitate the planning of the work, the Commission and the EFSA shall agree on a schedule for the delivery of the view of the EFSA on the draft review report and on the format in which that view is submitted.

▼B

Article 13

Finalised review report

Where the Commission submits a draft directive or a draft decision in accordance with Article 12, it shall at the same time submit the conclusions of the Committee's examination in the format of a finalised review report to be noted in the summary record of the meeting. The finalised review report, excluding any parts which refer to confidential information contained in the dossiers and determined as such in accordance with Article 14 of Directive 91/414/EEC, shall be made available for public consultation.

Article 14

Suspension of time limits

Where, in respect of a substance listed in Annex I, the Commission submits a proposal for a total prohibition under Directive 79/117/EEC, the time limits provided for in this Regulation shall be suspended until a decision on that proposal has been taken. Where the Council decides on the total prohibition of the substance in the Annex to Directive 79/117/EEC, the procedure under this Regulation shall be terminated.

Article 15

Measures taken by Member States

Any Member State which, on the basis of information contained in the dossiers referred to in Article 7 or in the report concerning an active substance referred to in Article 10, envisages taking action to withdraw from the market or to restrict severely the use of a plant-protection product containing that substance, shall, as soon as possible, inform the Commission, the EFSA, the other Members States and the notifiers giving the reasons for its intended action.

Article 16

Interim progress report

All Member States shall provide to the Commission and the EFSA a report of their progress on the evaluation of the active substances for which they are rapporteur. Such report shall be made by 30 November 2004 for the active substances mentioned in Annex I, part A, and by 30 November 2005 for those of Annex I, part B.

Article 17

Fees

1.  
Member States shall establish a regime obliging the notifiers to pay a fee or charge for the administrative treatment and the evaluation of dossiers.
2.  

For this purpose, the Member States shall:

(a) 

require the payment of a fee or charge for each submission of a dossier;

(b) 

ensure that the amount of the fee or charge shall be established in a transparent manner with the view to correspond to the real cost of the examination and administrative treatment of a dossier; however this does not exclude that Member States provide for a scale of fixed charges based on average costs for the calculation of the total fee;

▼M1

(c) 

ensure that the fee or charge is received in accordance with the instructions given by the organisation in each Member State listed in Annex IV and that the income from the fee or charge is used to finance exclusively the costs actually incurred by the Member State for the evaluation and administrative treatment of the dossiers for which that Member State is rapporteur or to finance general activities of the Member States resulting from Articles 9, 10 or 11;

▼B

(d) 

require that a first part of the fee or charge, covering the costs of the rapporteur Member State's obligations resulting from Article 6 and Article 9 is paid at the time of the submission of the data lists referred to in Article 6; this part will not be refundable under any circumstance.

Article 18

Other charges, taxes, levies or fees

Article 17 is without prejudice to Member States' rights to maintain or introduce, to the extent permitted under the Treaty, charges, taxes, levies or fees with regard to authorisation, placing on the market, use and control of active substances and plant-protection products other than the fee provided for in Article 17.

Article 19

Temporary measures

If necessary and on a case-by-case basis, the Commission may take appropriate temporary measures as provided for by the third subparagraph of Article 8(2) of Directive 91/414/EEC for uses for which additional technical evidence has been provided demonstrating the essential need for further use of the active substance and that there is no efficient alternative.

Article 20

Amendment to Regulation (EC) No 451/2000

Regulation (EC) No 451/2000 is amended as follows:

1. 

Article 8 is replaced by the following:

‘Article 8

Evaluation of dossiers by rapporteur Member States and the EFSA

1.  
The rapporteur Member State shall evaluate and report only on those active substances for which at least one dossier has been determined to be complete in accordance with Article 6(2) and (3). For such active substances it shall evaluate and report only on the complete dossiers and for the other dossiers it shall check the identity and impurities of the active substance. The rapporteur Member State shall take into consideration the information available on potentially dangerous effects in the other dossiers submitted by any notifier or by any third party in accordance with the provisions of Article 5(4)(d). It shall send a draft report of its assessment of the dossier to the European Food Safety Authority (EFSA) as quickly as possible, and at the latest 12 months after the dossier was determined to be complete. The draft assessment report shall be submitted in the format recommended in accordance with the procedure provided for in Article 19 of the Directive.

At the same time, the rapporteur Member State shall make a recommendation to the Commission either:

— 
to include the active substance in Annex I to the Directive, stating the conditions for inclusion, or
— 
not to include the active substance in Annex I to the Directive, stating the reasons for the non-inclusion.

The rapporteur Member State shall in particular include in the draft assessment report a reference to each test and study report, for each point of Annex II and Annex III to the Directive, relied on for the assessment. This reference shall be made in the form of a list of test and study reports including the title, the author(s), the date of the study or test report and the date of publication, the standard to which the test or study was conducted, the holder's name and, if any, the claim made by the holder or notifier for data protection. It shall also mention for the other notified sources of the active substances for which the dossier was considered not to be complete whether it can be concluded that such active substances are comparable within the meaning of Article 13(5) of the Directive.

2.  
Without prejudice to Article 7 of the Directive, submission of new studies shall not be accepted, except for the studies as referred to in Article 6(2)(c), third indent. The rapporteur Member State may request the notifiers to submit further data which are necessary to clarify the dossier. When doing so the rapporteur Member State shall set a time limit within which the information should be provided; this time limit shall not affect the time limit for the submission of the report referred to in paragraph 1.

The rapporteur Member State may, from the start of this examination, consult with experts from the EFSA and may request additional technical or scientific information from other Member States to assist the evaluation. The rapporteur Member State may perform the evaluation together with a co-rapporteur Member State.

The rapporteur Member State shall request the notifiers to submit an updated summary dossier to the EFSA, the other Member States and on request to the Commission at the same time as the rapporteur's draft assessment report is sent to the EFSA.

The Member States, the EFSA or the Commission may request through the rapporteur Member State that notifiers also send them the updated complete dossiers or parts thereof.

3.  
As soon as it becomes evident to a rapporteur Member State that it will be unable to comply with the time limit specified in paragraph 1 for the submission of the draft assessment report to the EFSA, it shall inform the Commission and the EFSA and give the reasons for the delay. All Member States shall provide to the Commission and the EFSA a report of their progress on the evaluation of the active substances for which they are rapporteur. Such report has to be made by 30 April 2003.
4.  
After receiving the updated summary dossier and the draft assessment report referred to in paragraph 1, the EFSA shall, within 30 days, acknowledge receipt of the report to the rapporteur Member State. In exceptional cases where the draft assessment report clearly does not fulfil the requirements concerning the format recommended by the Commission, the Commission shall agree with the EFSA and the rapporteur Member State on a period for resubmission of an amended report. This period shall not exceed four months.
5.  
The EFSA shall circulate the rapporteur's draft assessment report to the Member States and may organise a consultation of experts including the rapporteur Member State. The EFSA may consult some or all of the notifiers of active substances specified in Annex I on the report or parts of the report on the relevant active substance.

Without prejudice to Article 7 of the Directive, submission of new studies shall not be accepted. The rapporteur Member State, with the agreement of the EFSA, may request the notifiers to submit within specified periods further data considered by the rapporteur member state of the EFSA necessary to clarify the dossier.

6.  

The EFSA shall make available at specific request or keep available for consultation by any person the following:

(a) 

the information referred to in the last subparagraph of paragraph 1, except the elements thereof which have been accepted as confidential in accordance with Article 14 of the Directive;

(b) 

the name of the active substance;

(c) 

the content of the pure active substance in the manufactured material;

(d) 

the list of any data required for consideration of the possible inclusion of the active substance into Annex I to the Directive, first as contained in the rapporteur's report and secondly as finalised by the EFSA;

(e) 

the draft assessment report, except the elements thereof which have been accepted as confidential in accordance with Article 14 of the Directive.

7.  
The EFSA shall evaluate the rapporteur's draft assessment report and deliver its opinion on whether the active substance can be expected to meet the safety requirements of the Directive to the Commission at the latest one year after receipt of the rapporteur Member State draft assessment report. Where appropriate, the EFSA shall give its opinion on the available options claimed to meet the safety requirements. The Commission and the EFSA shall agree on a schedule for the delivery of the opinions in order to facilitate the planning of the work. The Commission and the EFSA shall agree on the format in which the opinion of the EFSA is submitted.
8.  

At the latest six months after receipt of the EFSA opinion referred to in paragraph 7, the Commission shall submit the draft review report. Without prejudice to any proposal it may submit with a view to amending the Annex to Directive 79/117/EEC, and on the basis of the finalised review report it shall submit to the Committee:

(a) 

a draft directive to include the active substance in Annex I to the Directive, setting out where appropriate the conditions, including the time limit, for such inclusion, or

(b) 

a draft decision addressed to the Member States to withdraw the authorisations of plant-protection products containing the active substance, pursuant to the fourth subparagraph of Article 8(2) of the Directive, whereby that active substance is not included in Annex I to the Directive, mentioning the reasons for the non-inclusion.

The directive or decision shall be adopted in accordance with the procedure provided for in Article 19 of the Directive.

9.  
Where the Commission submits a draft directive or a draft decision in accordance with paragraph 8, it shall at the same time submit the conclusions of the Committee's examination in the format of a finalised review report to be noted in the summary record of the meeting.

The finalised review report, excluding any parts which refer to confidential information contained in the dossiers and determined as such in accordance with Article 14 of the Directive, shall be made available for public consultation.’

2. 

In Article 10(4), the first sentence is replaced by the following:

‘The time limit for the submission of a list of available studies shall be 23 May 2003. A full data package shall be available on 23 May 2003 at the latest.’

3. 

In Article 11(2), the second sentence is replaced by the following:

‘Member States shall withdraw by 25 July 2003 authorisations of plant-protection products containing active substances for which no admissible notification has been submitted. Authorisations of plant-protection products containing active substances for which no list of available studies has been submitted or for which no full data package is available shall be withdrawn by the deadline referred to in the Decision on the non-inclusion of the active substance concerned.’

4. 

In Annex I, part A, in relation to the active substance Tolclofos-methyl ‘The Netherlands’ is replaced by ‘Sweden’.

Article 21

Entry into force

This Regulation shall enter into force on the seventh day following its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.




ANNEX I

List of active substances (column A), rapporteur Member States (column B) and notifying producers (code identification) (column C)

PART A



A

B

C

Name

Rapporteur Member State

Notifiers

Abamectin

Netherlands

IBE-ES

PRO-ES

SNO-FR

SYN-GB

Acetochlor

Spain

DAS-GB

MON-BE

RIV-IE

Amidosulfuron

Austria

AVS-DE

Benfluralin

Belgium

DAS-GB

MAK-BE

Bifenox

Belgium

FSG-DE

Bifenthrin

France

FMC-BE

Bitertanol

United Kingdom

BAY-DE

Bromuconazole

Belgium

AVS-FR

Buprofezin

Finland

NIH-GB

Butralin

France

CFP-FR

Carbetamide

France

FSG-DE

Chlorflurenol

Germany

SCC-DE

Chloridazon

Germany

BAS-DE

Chloropicrin

Italy

EBR-NL

RIV-IE

Chlorthal-dimethyl

Greece

AMV-GB

Cinosulfuron

Italy

SYN-GB

Clethodim

Netherlands

TOM-FR

Clofentezine

United Kingdom

MAK-BE

Clomazone

Denmark

FMC-BE

Coppercompounds

France

EUC-GB

Cresylic acid

Netherlands

ASP-NL

Cyanamide

Germany

DUS-DE

Cycloxydim

Austria

BAS-DE

Dichlorophen

Ireland

CCD-GB

Diclofop

France

AVS-DE

PPC-ES

Dicloran

Spain

MAI-PT

Diflubenzuron

Sweden

UNI-NL

Diflufenican

United Kingdom

AVS-DE

HRM-BE

MAK-BE

Dimethipin

Greece

CRO-GB

Dithianon

Greece

BAS-BE

HRM-BE

Epoxiconazole

Germany

BAS-DE

MAK-BE

Etofenprox

Italy

LKC-UK

Fenazaquin

Greece

DAS-GB

Fenbuconazole

United Kingdom

DAS-GB

Fenoxaprop-P

Austria

AVS-DE

Fenpropidin

Sweden

SYN-GB

Fenpropimorph

Germany

BAS-DE

Fenpyroximate

Germany

NIH-GB

Fluazifop-P

France

SYN-GB

Fluazinam

Austria

ISK-BE

Fludioxonyl

Denmark

SYN-GB

Fluometuron

Greece

MAK-BE

NLI-AT

Fluquinconazole

Ireland

AVS-FR

Flurenol

Germany

SCC-DE

Flutolanil

Finland

NIH-GB

Fuberidazole

United Kingdom

BAY-DE

Hexaflumuron

Portugal

DAS-GB

Hexythiazox

Finland

NPS-DE

Imidacloprid

Germany

BAY-DE

Kasugamycin

Netherlands

LAI-ES

Mefluidide

Ireland

MKC-BE

Mepiquat

United Kingdom

BAS-DE

Metaldehyde

Austria

LON-DE

Metazachlor

United Kingdom

BAS-DE

FSG-DE

MAK-BE

Methyl bromide

United Kingdom

EBR-NL

Myclobutanil

Belgium

DAS-GB

Napropamide

Denmark

UPL-GB

Nicosulfuron

United Kingdom

ISK-BE

Nuarimol

Portugal

DAS-GB

Pencycuron

Netherlands

BAY-DE

Polyoxin

Spain

LAI-ES

Pretilachlor

Italy

SYN-GB

Propaquizafop

Italy

MAK-BE

Prosulfocarb

Sweden

SYN-GB

Pyriproxyfen

Netherlands

SUM-FR

Quinoclamine

Sweden

AKA-DE

Streptomycine

Netherlands

DSM-NL

Tebufenozide

Germany

DAS-GB

▼M2 —————

▼B

Tetraconazole

Italy

ISA-IT

Thiobencarb

Spain

KCI-GB

Tralkoxydim

United Kingdom

SYN-GB

Triadimefon

United Kingdom

BAY-DE

Triadimenol

United Kingdom

BAY-DE

MAK-BE

Tridemorph

Germany

BAS-DE

Triflumizole

Netherlands

CRE-NL

Triflumuron

Italy

BAY-DE

Triflusulfuron

France

DPD-FR

Zeta-Cypermethrin

Belgium

FMC-BE

PART B



A

B

C

Name

Rapporteur Member State

Notifiers

8-Hydroxyquinoline

Spain

ASU-DE

PRO-ES

Aclonifen

Germany

AVS-DE

Acrinathrin

France

AVS-DE

Aluminium phosphide

Germany

DET-DE

Ammonium sulphamate

Ireland

DAP-GB

Asulam

United Kingdom

AVS-DE

Azocyclotin

Italy

CRX-FR

Bensulfuron

Italy

DPD-FR

Bupirimate

Netherlands

MAK-BE

Calcium phosphide

Germany

CFW-DE

Carboxin

United Kingdom

CRO-GB

Chlorate

France

ATO-FR

Chlormequat

United Kingdom

BCL-IE

CTF-AT

FSG-DE

PUS-FR

Chlorsulfuron

Greece

DPD-FR

Cyhexatin

Italy

CRX-FR

OXO-IT

Cymoxanil

Austria

CAL-FR

DPD-FR

OXO-IT

PUS-FR

Cyproconazole

Ireland

SYN-GB

Cyromazine

Greece

SYN-GB

Dazomet

Belgium

BAS-DE

Dicamba

Denmark

GHA-GB

SYN-GB

Dichlobenil

Netherlands

UNI-NL

Dichlorobenzoic acid methylester

Germany

ASU-DE

Dicofol

Spain

DAS-GB

MAK-BE

Diethofencarb

France

SUM-FR

Difenoconazole

Sweden

SYN-GB

Dimethachlor

Germany

SYN-GB

Diniconazole

France

SUM-FR

Diphenylamine

Ireland

CRX-FR

CSI-UK

Dodemorph

Netherlands

BAS-DE

Dodine

Portugal

CAG-BE

OXO-IT

Ethalfluralin

Greece

DAS-GB

Etridiazole

Netherlands

UNI-NL

Fenbutatin oxide

Belgium

BAS-BE

CRX-FR

Fenoxycarb

Netherlands

SYN-GB

Flamprop-M

Sweden

BAS-BE

Flufenoxuron

France

BAS-BE

Flurochloridone

Spain

MAK-BE

Flurprimidole

Finland

DAS-GB

Flutriafol

United Kingdom

CHE-DK

Guazatine

United Kingdom

MAK-BE

Hexaconazole

Italy

IQV-ES

SYN-GB

Hymexazol

Finland

TSG-GB

Imazamethabenz

United Kingdom

BAS-BE

Imazaquin

Belgium

BAS-BE

Imazethapyr

Italy

BAS-BE

Isoxaben

Sweden

DAS-GB

Lenacil

Belgium

HRM-BE

SCH-DE

Lufenuron

Portugal

SYN-GB

Magnesium phosphide

Germany

DET-DE

Metam

Belgium

FMF-ES

LAI-ES

MAK-BE

UCB-BE

Metamitron

United Kingdom

BAY-DE

BCL-IE

EXC-BE

FSG-DE

HRM-BE

MAK-BE

PUS-FR

UPL-GB

Methabenzthiazuron

Sweden

PUS-FR

Metosulam

France

BAY-DE

Monocarbamide-dihydrogensulphate

Spain

AGX-GB

Oryzalin

France

DAS-GB

Oxadiazon

Italy

AVS-DE

Oxyfluorfen

Spain

DAS-GB

MAK-BE

PPC-ES

Paclobutrazol

United Kingdom

SYN-GB

Penconazole

Germany

SYN-GB

Picloram

United Kingdom

DAS-GB

Primisulfuron

Austria

SYN-GB

Prochloraz

Ireland

AVS-FR

BCL-IE

MAK-BE

PUS-FR

SPC-FR

Propachlor

Netherlands

MAK-BE

MON-BE

Propanil

Italy

DAS-GB

MAK-BE

RCO-PT

Propargite

France

CRO-GB

PPC-ES

Pyridaben

Netherlands

NCI-DE

Quinclorac

Portugal

BAS-DE

Quinmerac

United Kingdom

BAS-DE

Quizalofop-P

Finland

CRO-GB

MAK-BE

NCI-DE

Sintofen

France

DPD-FR

Sodium 5-nitroguaiacolate

Greece

CAL-FR

Sodium o-nitrophenolate

Greece

CAL-FR

Sodium p-nitrophenolate

Greece

CAL-FR

Sodium tetrathiocarbonate

Spain

AGX-GB

Sulcotrione

Germany

BAY-DE

Tau-fluvalinate

Denmark

MAK-BE

Tebuconazole

Denmark

BAY-DE

MAK-BE

Tebufenpyrad

Germany

BAS-BE

▼M2

Teflubenzuron

United Kingdom

BAS-BE

▼B

Tefluthrin

Germany

SYN-GB

Terbuthylazine

United Kingdom

MAK-BE

OXO-IT

SYN-GB

Thidiazuron

Spain

AVS-FR

Tri-allate

United Kingdom

MON-BE

Triazoxide

United Kingdom

BAY-DE

Tricyclazole

France

DAS-GB




ANNEX II

List of notifiers' code identification, names and addresses



Code identification

Name

Address

AGX-GB

Agrilex UK Ltd

PO Box 31

Robertsbridge

TN32 5ZL

United Kingdom

Tel. (44-1580) 88 20 59

Fax (44-1580) 88 20 57

AKA-DE

Agro-Kanesho Co., Ltd, European Branch

Stader Elbstraße

D-21683 Stade

Tel. (49-41) 41 40 83 88

Fax (49-41) 41 40 83 90

AMV-GB

Amvac Chemical UK Ltd

Surrey Technology Centre,

40 Occam Rd

The Surrey Research Park

Guildford,

Surrey GU2 5YG

United Kingdom

Tel. (44-1483) 29 57 80

Fax (44-1483) 29 57 81

ASP-NL

Asepta BV

Cyclotronweg 1 / P.O. Box 33

2600 AA Delft

Nederland

Tel. (31-15) 256 92 10

Fax (31-15) 257 19 01

ASU-DE

Stähler Agrochemie GmbH & Co. KG

Postfach 2047

D-21680 Stade

Tel. (49-41) 41 92 04-0

Fax (49-41) 41 92 04-10

ATO-FR

Atofina

4-8, cours Michelet

F-92800 Puteaux

Tel. (33-1) 49 00 80 80

Fax (33-1) 49 00 88 80

AVS-DE

Aventis CropScience GmbH

Industriepark Höchst

Gebäude K 607

D-65926 Frankfurt am Main

Tel. (49-69) 305 66 99

Fax (49-69) 305 176 69

AVS-FR

Aventis CropScience SA

14-20, rue Pierre Baizet

BP 9163

F-69263 Lyon Cedex 09

Tel. (33-4) 72 85 25 25

Fax (33-4) 72 85 30 81

BAS-BE

BASF (Belgium)

Global Regulatory Affairs — APD/RF

Avenue Hamoir, 14

B-1180 Bruxelles

Tel. (32-2) 373 27 11

Fax (32-2) 373 27 00

BAS-DE

BASF AG (Deutschland)

Agricultural Center

PO Box 120

D-67114 Limburgerhof

Tel. (49-621) 60-0

Fax (49-621) 60-27701

BAY-DE

Bayer AG

Business Group Crop Protection

Agricultural Centre Monheim

D-51368 Leverkusen

Tel. (49-2173) 38 49 28

Fax (49-2173) 38 37 35

BCL-IE

Barclay Chemicals Ltd

Tyrellstown Way

Damastown Industrial Park

Mulhuddart

Dublin 15

Ireland

Tel. (353-18) 42 57 55

Fax (353-18) 42 53 81

CAG-BE

Chimac-Agriphar SA

26, rue de Renory

B-4102 Ougrée

Tel. (32-4) 385 97 46

Fax (32-4) 385 97 49

CAL-FR

Calliope SAS

Route d'Artix

BP 80

F-64150 Noguères

Tel. (33-5) 59 60 92 92

Fax (33-5) 59 60 92 19

CCD-GB

Coalite Chemicals Division

PO Box 152

Buttermilk Lane

Bolsover

Chesterfield

Derbyshire S44 6AZ

United Kingdom

Tel. (44-1246) 82 68 16

Fax (44-1246) 24 03 09

CFP-FR

CFPI Nufarm

Regulatory Affairs Dept.

28, boulevard Camélinat

F-92230 Gennevilliers

Tel. (33-1) 40 85 50 20

Fax (33-1) 40 85 51 56

CFW-DE

Chemische Fabrik Wülfel GmbH & Co. KG

Hildesheimer Straße 305

D-30519 Hannover

Tel. (49-511) 98 49 60

Fax (49-511) 984 96 40

CHE-DK

Cheminova A/S

Thyborønvej 76-78

DK-7673 Harboøre

Tel. (45) 96 90 96 90

Fax (45) 96 90 96 91

CRE-NL

Certis Europe BV

Straatweg 30B

PO Box 1180

3600 BD Maarssen

Nederland

Tel. (31-346) 55 24 00

Fax (31-346) 55 42 74

CRO-GB

Crompton Europe Ltd

Registration Department

Kennet House

4 Langley Quay

Slough

Berkshire

SL3 6EH

United Kingdom

Tel. (44-17) 53 60 30 00

Fax (44-17) 53 60 30 77

CRX-FR

Cerexagri

Registration Department

1, rue des Frères Lumière

F-78370 Plaisir

Tel. (33-1) 30 81 73 00

Fax (33-1) 30 81 72 51

CSI-UK

CSI-Europe

Pentlands Science Park

Penicuik

Edinburgh

EH26 0PZ

United Kingdom

Tel. (44-131) 445 60 82

Fax (44-131) 445 60 85

CTF-AT

CCC Task Force

c/o Nufarm GmbH & Co KG

St.-Peter-Straße 25

A-4021 Linz

Tel. (43-732) 69 18 23 13

Fax (43-732) 69 18 20 04

DAP-GB

Dax Products Ltd

76 Cyprus Road

Nottingham

NG3 5ED

United Kingdom

Tel. (44-11) 59 26 9996

Fax (44-11) 59 66 1173

DAS-GB

Dow AgroSciences

Letcombe Laboratory

Letcombe Regis

Wantage

Oxon

OX12 9JT

United Kingdom

Tel. (49-69) 78 99 60

Fax (49-69) 97 84 24 77

DET-DE

Detia Freyberg GmbH

Dr.-Werner-Freyberg-Straße 11

D-69514 Laudenbach

Tel. (49-6201) 70 80

Fax (49-6201) 70 84 27

DPD-FR

DuPont de Nemours (France) SAS

Crop Protection Products

137, rue de l'Université

F-75334 Paris Cedex 07

Tel. (33-1) 45 50 65 50

Fax (33-1) 45 50 60 05

DSM-NL

DSM Food Specialties, Agri Ingredients

Alexander Fleminglaan 1

PO Box 1

2600 MA Delft

Nederland

Tel. (31-15) 279 91 11

Fax (31-15) 279 34 82

DUS-DE

Degussa AG

Dr.-Albert-Frank-Straße 32

D-83308 Trostberg

Tel. (49-8621) 86-0

Fax (49-8621) 86 22 52

EBR-NL

Eurobrom BV

Regulatory Affairs Department

Verrijn Stuartlaan 1c

2288 EK Rijswijk

Nederland

Tel. (31-70) 3 408 408

Fax (31-70) 3 999 035

EUC-GB

European Union Copper Task Force

c/o TSGE

Conyngham Hall

Knaresborough

North Yorkshire

HG5 9AY

United Kingdom

Tel. (44-1423) 79 91 51

Fax (44-1423) 79 91 55

EXC-BE

Excel Industries Ltd

Luithagen Haven 9

B-2030 Antwerpen

Tel. (32-3) 239 82 24

Fax (32-3) 239 82 69

FMC-BE

FMC Chemical SPRL

Agricultural Products Group

Boulevard de la Plaine 9/3

B-1050 Bruxelles

Tel. (32-2) 645 95 84

Fax (32-2) 645 96 55

FMF-ES

FMC Foret SA

Córcega 293

E-08008 Barcelona

Tel. (34) 934 16 75 17

Fax (34) 934 16 74 13

FSG-DE

Feinchemie Schwebda GmbH

Straßburger Straße 5

D-37269 Eschwege

Tel. (49-221) 94 98 14-0

Fax (49-221) 94 98 14 15

GHA-GB

Gharda Chemicals Ltd Europe

Holbrook House

72 Lower Addiscombe Road

Croydon

CR9 6AD

United Kingdom

Tel. (44-2086) 55 41 03

Fax (44-2086) 55 41 02

HRM-BE

Hermoo Belgium NV

Zepperenweg 257

B-3800 Sint-Truiden

Tel. (32-11) 68 68 66

Fax (32-11) 70 74 84

IBE-ES

Iberotam SA

Muntaner, 322, 12a

E-08021 Barcelona

Tel. (34) 934 54 34 64

Fax (34) 934 54 89 21

IQV-ES

Industrias Químicas del Vallés SA

Av. Rafael Casanova 81

E-08100 Mollet del Vallès ( Barcelona)

Tel. (34) 935 79 66 77

Fax (34) 935 93 80 11

ISA-IT

Isagro SPA

Registration Department

Centro Uffici San Siro Fabbricato D ala 3 Via Caldera, 21

I-20153 Milano

Tel. (39-02) 40 90 11

Fax (39-02) 40 90 12 87

ISK-BE

ISK Biosciences Europe SA

Tour ITT

Avenue Louise 480 bte 12

B-1050 Bruxelles

Tel. (32-2) 627 86 11

Fax (32-2) 627 86 00

KCI-GB

Kumiai Chemical Industry Co., Ltd

London Liaison Office

35 Piccadilly

London

W1J 0DW

United Kingdom

Tel. (44-2077) 34 72 82

Fax (44-2077) 34 45 61

LAI-ES

Lainco, SA

Polígono Can Jardí

Av. Bizet 8-12

E-08191 Rubí ( Barcelona)

Tel. (34) 935 86 20 15

Fax (34) 935 86 20 16

LKC-UK

Landis Kane Consulting

PO Box 383

Cheltenham

Gloucestershire

GL52 6WD

United Kingdom

Tel. (44-4161) 906 85 04

Fax (44-4161) 906 85 09

LON-DE

Lonza GmbH

Morianstraße 32

Postfach 13 14 53

D-42041 Wuppertal

Tel. (49-202) 245 38-0

Fax (49-202) 245 38 10

MAI-PT

Margarita Internacional

Comércio e Serviços, Limitada

Rua do Bom Jesus, 18-3.o Esq.o

P-9050-028 Funchal

Tel. (351-291) 23 24 84

MAK-BE

Makhteshim Agan

International Coordination Center (MAICC)

Avenue Louise 283

B-1050 Bruxelles

Tel. (32-2) 646 86 06

Fax (32-2) 646 91 52

MKC-BE

McKenna & Cuneo, L.L.P.

56, rue des Colonies, Box 14

B-1000 Bruxelles

Tel. (32-2) 278 12 11

Fax (32-2) 278 12 00

MON-BE

Monsanto Europe SA

Regulatory Department

Avenue de Tervuren 270-272

B-1150 Bruxelles

Tel. (32-10) 49 42 11

Fax (32-10) 49 42 42

NCI-DE

Nissan Chemical Europe GmbH

Deutsch-Japanisches Center

Immermannstraße 45

D-40210 Düsseldorf

Tel. (49-211) 17 22 70

Fax (49-211) 16 22 43

NIH-GB

Nihon Nohyaku Co., Ltd

8 Cork Street

Mayfair

London

W1S 3LJ

United Kingdom

Tel. (44-2074) 34 00 33

Fax (44-2072) 87 13 35

NLI-AT

Nufarm GmbH & Co KG

St.-Peter-Straße 25

A-4021 Linz

Tel. (43-73) 26 91 80

Fax (43-73) 26 91 82 004

NPS-DE

Nisso Chemical Europe GmbH

Berliner Allee 29/Ecke Steinstraße

D-40212 Düsseldorf

Tel. (49-211) 323 01 35

Fax (49-211) 32 82 31

OXO-IT

Oxon Italia SpA

Via Sempione, 195

I-20016 Pero( MI)

Tel. (39-02) 35 37 81

Fax (39-02) 339 02 75

PPC-ES

Proplan-Plant Protection Company, SL

Vía de las dos Castillas 11. Bloque 3, 1o C.

E-28224 Pozuelo de Alarcón ( Madrid)

Tel. (34) 913 52 29 60

Fax (34) 913 52 72 82

PRO-ES

Probelte, SA

Ctra. Madrid Km. 384.6

Polígono Industrial El Tiro

E-30100 Espinardo ( Murcia)

Tel. (34) 968 30 72 50

Fax (34) 968 30 54 32

PUS-FR

Phytorus SA

Parc d'Ariane, Bât B

11, boulevard de la grande Thumine

F-13090 Aix-en-Provence

Tel. (33-1) 60 27 26 26

Fax (33-4) 42 52 68 52

RCO-PT

Rice Madeira Company Europe

Comércio Internacional e Serviços, Sociedade Unipessoal Lda.

Rua 31 de Janeiro n.o 81-A, 5.o E

PT-9050-011 Funchal ( Madeira)

Tel. (351-291) 22 77 44

Fax (351-291) 22 66 31

RIV-IE

Rivendell Consulting Ltd

Rivendell House

Stamullen

County Meath

Ireland

Tel. (353-18) 41 52 95

Fax (353-18) 41 47 68

SCC-DE

SCC Scientific Consulting Company GmbH

Mikroforum Ring 1

D-55234 Wendelsheim

Tel. (49-67) 34 91 90

Fax (49-67) 34 91 91 91

SCH-DE

Dr. Schirm AG

Kipper Straße 9-11

D-44147 Dortmund

Tel. (49-392) 845 63 02

Fax (49-392) 845 63 00

SNO-FR

SINON EU Corporation

170, boulevard Haussmann

F-75008 Paris

Tel. (33-5) 59 60 92 92

Fax (33-5) 59 60 92 19

SPC-FR

Sipcam-Phyteurop

Courcellor 2

35, rue d'Alsace

F-92531 Levallois-Perret Cedex

Tel. (33-1) 47 59 77 00

Fax (33-1) 47 37 54 52

SUM-FR

Sumitomo Chemical Agro Europe SA

2, rue Claude Chappe

F-69370 Saint-Didier-au-Mont-d'Or

Tel. (33-4) 78 64 32 60

Fax (33-4) 78 47 70 05

SYN-DE

Syngenta Agro GmbH

Am Technologiepark 1-5

Postfach 110353

D-63477 Maintal

Tel. (49-6971) 55-0

Fax (49-6971) 55-319

SYN-GB

Syngenta Europe Ltd

European Regional Centre

Priestley Road

Surrey Research Park

Guildford

Surrey

GU2 7YH

United Kingdom

Tel. (44-1483) 26 00 00

Fax (44-1483) 26 00 19

TOM-FR

Tomen France

18, avenue de l'Opéra

F-75001 Paris

Tel. (33-1) 42 96 14 56

Fax (33-1) 42 97 52 91

TSG-GB

Sankyo Company Ltd

C/o TSGE

Conyngham Hall

Knaresborough

North Yorkshire

HG5 9AY

United Kingdom

Tel. (44-1423) 79 91 51

Fax (44-1423) 79 91 55

UCB-BE

UCB Chemicals NV

Allée de la Recherche 60

B-1070 Bruxelles

Tel. (32-2) 559 99 99

Fax (32-2) 559 99 00

UNI-NL

Uniroyal Chemical Europe BV

Registration Department

Ankerweg 18

1041 AT Amsterdam

Nederland

Tel. (31-20) 587 18 60

Fax (31-20) 587 18 68

UPL-GB

United Phosphorus Ltd

Chadwick House

Birchwood Park

Warrington

Cheshire

WA3 6AE

United Kingdom

Tel. (44-1925) 81 99 99

Fax (44-1925) 81 74 25




ANNEX III

Coordinating authority in the Member States (more details are available at the following website: http://www.europa.eu.int/comm/food/fs/ph_ps/pro/index_en.htm)

AUSTRIA

Bundesamt für Ernährungssicherheit

Landwirtschaftliche Untersuchungen und Forschung Wein

Spargelfeldstraße 191

A-1220 Wien

BELGIUM

Ministère des classes moyennes et de l'agriculture

Service Qualité des matières premières et analyses

WTC 3, 8e étage

Boulevard S. Bolivar 30

B-1000 Bruxelles

DENMARK

Ministry of Environment and Energy

Danish Environmental Protection Agency

Pesticide Division

Strandgade 29

DK-1401 Copenhagen K

GERMANY

Biologische Bundesanstalt für Land- und Forstwirtschaft (BBA)

Abteilung für Pflanzenschutzmittel und Anwendungstechnik (AP)

Messeweg 11-12

D-38104 Braunschweig

GREECE

Hellenic Republic

Ministry of Agriculture

General Directorate of Plant Produce

Directorate of Plant Produce Protection

Department of Pesticides

3-4 Hippokratous Street

GR-10164 Athens

SPAIN

Ministerio de Agricultura, Pesca y Alimentación

Dirección General de Agricultura

Subdirección General de Medios de Producción Agrícolas

Ciudad de Barcelona, 118-120

E-28007 Madrid

FINLAND

Kasvintuotannon tarkastuskeskus

Torjunta-aineet

PL 42

FIN-00501 Helsinki

FRANCE

Ministère de l'agriculture, de l'alimentation, de la pêche et des affaires rurales

Sous-direction de la qualité et de la protection des végétaux

Bureau de la réglementation et de la mise sur le marché des intrants

251, rue de Vaugirard

F-75732 Paris Cedex 15

IRELAND

Pesticide Control Service

Department of Agriculture and Food

Abbotstown Laboratory Complex

Abbotstown, Castleknock

Dublin 15

Ireland

ITALY

Ministero della Salute

Direzione generale della Sanità pubblica veterinaria degli alimenti e della nutrizione

Piazza G. Marconi, 25

I-00144 Roma

LUXEMBOURG

Administration des services techniques de l'agriculture

Service de la protection des végétaux

Boîte postale 1904

16, route d'Esch

L-1019 Luxembourg

NETHERLANDS

College voor de Toelating van Bestrijdingsmiddelen

Postbus 217

6700 AE Wageningen

Nederland

PORTUGAL

Direcção-Geral de Protecção das Culturas

Quinta do Marquês

P-2780 Oeiras

SWEDEN

Kemikalieinspektionen

Box 1384

S-17127 Solna

UNITED KINGDOM

Pesticides Safety Directorate

Department for Environment, Food and Rural Affairs

Mallard House

Kings Pool

3 Peasholme Green

York YO1 7PX

United Kingdom




ANNEX IV

Organisations in the Member States to be contacted concerning further details on the payment of the fees referred to in Article 17 and to which such fees have to be paid

AUSTRIA

Bundesamt für Ernährungssicherheit

Landwirtschaftliche Untersuchungen und Forschung Wein

Spargelfeldstraße 191

A-1220 Wien

BELGIUM

Fonds budgétaire des matières premières

Ministère des classes moyennes et de l'agriculture

Inspection générale des matières premières et produits transformés, WTC 3

Boulevard S. Bolivar 30

B-1000 Bruxelles

Account number 679-2005985-25 (Banque de la Poste)

DENMARK

Ministry of Environment and Energy

Danish Environmental Protection Agency

Strandgade 29

DK-1401 Copenhagen K

GERMANY

Biologische Bundesanstalt für Land- und Forstwirtschaft

Abteilung für Pflanzenschutzmittel und Anwendungstechnik

Messeweg 11-12

D-38104 Braunschweig

GREECE

Hellenic Republic

Ministry of Agriculture

General Directorate of Plant Produce

Directorate of Plant Produce Protection

Department of Pesticides

3-4 Hippokratous Street

GR-10164 Athens

SPAIN

Ministerio de Agricultura, Pesca y Alimentación

Dirección General de Agricultura

Subdirección General de Medios de Producción Agrícolas

Ciudad de Barcelona, 118-120

E-28007 Madrid

FINLAND

Kasvintuotannon tarkastuskeskus

Torjunta-aineet

PL 42

FIN-00501 Helsinki

Bank and account:

LEONIA BANK PLC

PSP BFIHH

800015-18982

FRANCE

Ministère de l'agriculture et de la pêche

Bureau de la réglementation des produits antiparasitaires

251, rue de Vaugirard

F-75732 Paris Cedex 15

IRELAND

Pesticide Control Service

Department of Agriculture, Food and Rural Development

Abbotstown Laboratory Complex

Abbotstown, Castleknock

Dublin 15

Ireland

ITALY

Tesoreria provinciale dello Stato di Viterbo

Post current account number: 11281011

LUXEMBOURG

Administration des services techniques de l'agriculture

Boîte postale 1904

L-1019 Luxembourg

THE NETHERLANDS

College voor de Toelating van Bestrijdingsmiddelen

Postbus 217

6700 AE Wageningen

Nederland

PORTUGAL

Direcção-Geral de Protecção das Culturas

Quinta do Marquês

P-2780 Oeiras

Account number: 003505840003800793097

Bank: Caixa Geral de Depósitos

SWEDEN

Kemikalieinspektionen

Box 1384

S-17127 Solna

National Giro Account: 4465054-7

UNITED KINGDOM

Pesticides Safety Directorate

Department for Environment, Food and Rural Affairs

Mallard House

Kings Pool

3 Peasholme Green

York YO1 7PX

United Kingdom

▼M3




ANNEX V

Criteria for clear indications of no harmful effects

An active substance shall be considered as fulfilling the requirement, as referred to in Article 11b, of there being clear indications that it may be expected that it does not have any harmful effects on human or animal health or on groundwater or any unacceptable influence on the environment if all the criteria set out in points 1 and 2 are met.

1.

The active substance satisfies the following criteria:

(a) 

it is not classified or proposed for classification as C (carcinogenic effects) M (mutagenic effects) R (toxic to reproduction) in categories 1, 2 or 3 in accordance with Directive 67/548/EEC;

(b) 

either not requested or, if required, an ADI (Acceptable Daily Intake), AOEL (Acceptable Operator Exposure Level) and ARfD (Acute Reference Dose) can be established on the basis of the standard assessment factor of 100;

(c) 

it is not considered to have the potential to meet the criteria of a persistent organic pollutant set out in Regulation (EC) No 850/2004 of the European Parliament and of the Council ( 10 );

(d) 

it is not considered to have the potential to meet the criteria set out in Annex XIII to the Regulation (EC) No 1907/2006 of the European Parliament and of the Council ( 11 ).

2.

At least one supported representative use of the active substance satisfies all of the following criteria:

(a) 

operator exposure is less than or equal to 75 % of the AOEL in modelled scenarios, considered relevant for the intended use and where the use of such modelling is appropriate to the supported use and at maximum using gloves as personal protective equipment (PPE);

(b) 

bystander exposure and worker exposure is less than or equal to 75 % AOEL in modelled scenarios, considered relevant for the intended use and where the use of such modelling is appropriate to the supported use and without the use of PPE;

(c) 

consumer exposure is less than or equal to 75 % of the ADI or ARfD (where such a value is necessarily established) in all available EU consumer diets on the basis of the MRLs (Maximum Residues Level) proposed for the active substance (without special refinements);

(d) 

leaching to groundwater is below 0,1 μg/l in at least half of the scenarios considered relevant for the intended use, or in relevant lysimeter/field studies, for both the parent substance and relevant metabolites;

(e) 

buffer zones for the protection of the environment do not exceed 30m without any further risk mitigation measures (e.g. drift reducing nozzles);

(f) 

the risk to non-target organisms is acceptable based on standard refinements.




ANNEX VI

Criteria for clear indications of harmful effects

An active substance shall be considered as fulfilling the requirement, as referred to in Article 11f, of there being clear indications that on the basis on the available data, and which are evaluated in accordance with the provisions of Article 11d, it may be expected that it has harmful effects on human or animal health or on groundwater if either the criterion in point 1 or one of the criteria in point 2 is met.

1.

As regards the active substance, the existing evidence is not sufficient to allow the establishment of an ADI, ARfD or an AOEL and such values are necessary to conduct a consumer and operator risk assessment.

2.

As regards each supported representative use, at least one of the following criteria is met:

(a) 

operator exposure is greater than 100 % AOEL in all modelled scenarios with the use of PPE/RPE (Personal Protective Equipment/Respiratory Protective Equipment), where the use of such modelling is appropriate to the supported use, and where actual exposure data, if available, also indicate that the AOEL will be exceeded under normal conditions of use;

(b) 

bystander exposure and worker exposure is greater than 100 % AOEL in modelled scenarios, where the use of such modelling is appropriate to the supported use, and where actual exposure data, if available, indicate that the AOEL will be exceeded for these groups under normal conditions of use;

(c) 

consumer exposure is greater than 100 % of the ADI or ARfD (where such a value is required) in at least one of the available EU consumer diets on the basis of the MRLs (Maximum Residues Level) proposed for the active substance;

(d) 

leaching to groundwater is equal to or above 0,1 μg/l in all modelled scenarios either for the parent substance or for relevant metabolites.



( 1 )  OJ L 230, 9.8.1991, p. 1.

( 2 )  OJ L 148, 6.6.2002, p. 19.

( 3 )  OJ L 366, 15.12.1992, p. 10.

( 4 )  OJ L 259, 13.10.2000, p. 27.

( 5 )  OJ L 55, 29.2.2000, p. 25.

( 6 )  OJ L 31, 1.2.2002, p. 1.

( 7 )  OJ L 33, 8.2.1979, p. 36.

( 8 ) Opinion of the Scientific Steering Committee of 28 May 1999 on anti-microbial resistance.

( 9 )  OJ L 15, 18.1.2008, p. 5. ◄

( 10 )  OJ L 158, 30.4.2004, p. 7; corrected by OJ L 229, 29.6.2004, p. 5.

( 11 )  OJ L 396, 30.12.2006, p. 1; corrected by OJ L 136, 29.5.2007, p. 3.

Top